FTC Wants Patent Prosecution Docs In Androgel Fight
The fight over discoverable documents in a pay-for-delay suit over testosterone replacement treatment AndroGel continued Thursday, when the Federal Trade Commission filed three motions seeking to force AbbVie Inc. and other...To view the full article, register now.
Already a subscriber? Click here to view full article